The prevalence of mandated and voluntary health information on alcohol products in Australia
Australian and New Zealand Journal of Public Health · 2025
DOI: 10.1016/j.anzjph.2024.100215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Australian and New Zealand Journal of Public Health, 2025. Verfasst von Simone Pettigrew und 13 weiteren Autor:innen. Beteiligte Einrichtung: The George Institute for Global Health, Australia. Electronic address: spettigrew@georgeinstitute.org.au. Hauptthemen laut MEDLINE: Alcoholic Beverages, Product Labeling, Alcohol Drinking, Health Promotion. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
OBJECTIVE: Regulations to restrict alcohol promotion and requirements for mandatory display of information about health risks associated with alcohol use have been minimal and hard-won in Australia. This study (i) outlines an approach to monitoring alcohol industry use of health messages on alcohol products and (ii) reports prevalence and nature of government-mandated health-related information and voluntary health messages on alcohol products. METHODS: Images of 5,923 alcohol products sold in four large alcohol stores in Sydney were captured. Data were collected in-store and via web-scraping. Label content was extracted from the images. RESULTS: There was high compliance (97%-99%) with government-mandated requirements other than the pregnancy warning label (63%). Presence of voluntary health-related messages was common (65%), but typically present in the form of DrinkWise (an industry-led social aspects/public relations organisation) statements that are unlikely to be effective. CONCLUSIONS: This study provides a unique and systematic approach to examining alcohol industry compliance with government-mandated on-product information requirements and voluntary inclusion of other health-related messages. IMPLICATIONS FOR PUBLIC HEALTH: The results demonstrate the need for ongoing monitoring to enforce alcohol industry compliance with Australia's existing and future labelling regulations and to assess the industry's voluntary use of other forms of health messaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The George Institute for Global Health, Australia. Electronic address: spettigrew@georgeinstitute.org.au.
- The George Institute for Global Health, Australia.
- Melbourne Law School, University of Melbourne, Australia.
- National Centre for Education and Training on Addiction (NCETA), Flinders University, Australia.
- Foundation for Alcohol Research and Education (FARE), Australia.
- Cancer Council Western Australia, Australia.
Förderung
- National Health and Medical Research Council
Zitieren
APA
Pettigrew, S., Yusoff, A., Sträuli, B., Booth, L., O'Brien, P., Bowden, J., Brownbill, A., Stafford, J., Jongenelis, M. I., Davies, T., Chikritzhs, T., Stockwell, T., Taylor, F., & Jones, A. (2025). The prevalence of mandated and voluntary health information on alcohol products in Australia. Australian and New Zealand Journal of Public Health. https://doi.org/10.1016/j.anzjph.2024.100215
Vancouver
Pettigrew S, Yusoff A, Sträuli B, Booth L, O'Brien P, Bowden J, et al. The prevalence of mandated and voluntary health information on alcohol products in Australia. Australian and New Zealand Journal of Public Health. 2025. doi:10.1016/j.anzjph.2024.100215
BibTeX
@article{Pettigrew2025,
author = {Pettigrew, Simone and Yusoff, Asad and Sträuli, Bella and Booth, Leon and O'Brien, Paula and Bowden, Jacquie and Brownbill, Aimee and Stafford, Julia and Jongenelis, Michelle I and Davies, Tazman and Chikritzhs, Tanya and Stockwell, Tim and Taylor, Fraser and Jones, Alexandra},
title = {The prevalence of mandated and voluntary health information on alcohol products in Australia},
journal = {Australian and New Zealand Journal of Public Health},
year = {2025},
doi = {10.1016/j.anzjph.2024.100215}
}
EUVIMED